YAP/miR-524-5p axis negatively regulates TXNIP expression to promote chondrosarcoma cell growth.

Ri-Xu Liu,Wang Tang,Bo-Yuan Zheng,Yong Yang,Zhen-Yan Li,Tao Gui,Huan-Tian Zhang,Ning Liu,Zhen-Gang Zha,Jing-Xiang Li

DOI: https://doi.org/10.1016/j.bbrc.2021.12.052

IF: 3.1

2021-01-01

Biochemical and Biophysical Research Communications

Abstract:Chondrosarcoma (CHS) is the second most common bone malignant tumor and currently has limited treatment options. We have recently demonstrated that thioredoxin interacting protein (TXNIP) plays a crucial role in the oncogenesis of bone sarcoma, yet its implication in CHS is underdetermined. In the present study, we first found that knockdown of TXNIP promotes the proliferation of CHS cell largely through increasing their glycolytic metabolism, which is well-known as Warburg effect for providing energy. Consistent with our previous report that YAP is fundamental for CHS cell growth, herein we revealed that YAP functioned as an upstream molecule of TXNIP, and that YAP negatively regulated TXNIP mRNA and protein expression both in vitro and in vivo. Mechanistically, although knockdown of YAP upregulated both the nuclear and cytoplasmic TXNIP expression, we did not observe any obvious interaction between YAP and TXNIP; instead, miRNA-524-5p was demonstrated to be required for YAP-regulated TXNIP expression and thus controlling CHS cell growth. Together, our study reveals that TXNIP is a tumor suppressor in terms of CHS, and that the YAP/miRNA-524-5p/TXNIP signaling axis may provide a novel clue for CHS targeted therapy.